MedPath

The Effect of a Liquid Protein Modular on Growth and Outcomes in the NICU

Not Applicable
Completed
Conditions
Problem With Growth of an Infant
Registration Number
NCT01609868
Lead Sponsor
University of Nebraska
Brief Summary

The investigators hypothesis that premature infants receiving a commercially available liquid protein modular will have improved growth when compared with premature infants receiving a commercially available powder protein modular.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Infants less than 2000 gms at birth, receiving maternal breast milk
Exclusion Criteria
  • Infants receiving formula

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Growth in premature infants (percentile ranking at 36 weeks CGA)birth to 36 weeks
Secondary Outcome Measures
NameTimeMethod
GI tolerancebirth to 36 weeks

abdominal distention, feeding tolerance

Trial Locations

Locations (1)

Alegent Bergan Hospital

🇺🇸

Omaha, Nebraska, United States

Alegent Bergan Hospital
🇺🇸Omaha, Nebraska, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.